Press release content from Globe Newswire. The AP news staff was not involved in its creation.
DIACCURATE acquires BIOKINESIS to create a sole-in-class biotech player in oncology and .
DIACCURATEJanuary 12, 2021 GMT
Dr. Dominique BRIDON leads the new entity
DIACCURATE is now developing 3 programs in cancer and immunotherapy
DIACCURATE will be initiating a first clinical trial by early 2022
Paris, France, January 12, 2021
By acquiring BIOKINESIS, a French biotech that develops the very first anticancer compound targeting the Golgi apparatus, DIACCURATE comforts its “sole-in-class” therapeutic strategy in oncology and immunotherapy. The company is developing a new generation of drug candidates which relies on novel mechanisms of action and untapped cellular and subcellular compartments. Initial data already suggest that this highly innovative approach could help to improve resitance to cancer progression and extend the benefits of immunotherapy to more indications and pati
Dry January invites folks to ditch the booze in favor of non-alcoholic alternatives
Sign In
Andrea Valluzzo
FacebookTwitterEmail
1of5
Athletic Brewing Company based in Stratford is Connecticut s only nonalcoholic brewery.Contributed photoShow MoreShow Less
2of5
Bill Shufelt co-founded Athletic Brewing Company based in Stratford.Athletic Brewing Company / Contributed photoShow MoreShow Less
3of5
4of5
Lauren Timmerman, clinical nutrition manager at Norwalk Hospital, said mocktails are a healthy alternative as they often incorporate superfoods.Lauren Timmerman / Contributed photoShow MoreShow Less
5of5
Breaking a habit is hard and whether you’re looking to switch to a teetotaler lifestyle or are just sober-curious, the Dry January movement is when many people jump onto the wagon, even if only as a temporary measure. Given the plethora of alcohol-free options today, there hasn’t been a better time to go dry.
USA Oncology Centers Opens with Innovative Therapies to Treat Liver Cancer
Share Article
USA Oncology Centers are dedicated to helping patients discover hope for a healthier life. NORTHBROOK, Ill. (PRWEB) December 14, 2020 USA Oncology Centers, the newest division of USA Clinics Group, announced today it has been granted a radioactive materials license to offer targeted internal radiation to treat patients with metastatic liver cancer. The new state-of-the-art outpatient clinic will welcome patients beginning Monday, December 14 at 162-03, Ste. 200, Jamaica Avenue in Jamaica, New York.
“Every aspect of our new oncology center has been designed with the patient’s overall cancer care in mind to provide the best clinical outcomes and patient experience,” said Founder and CEO, USA Clinics Group, Yan Katsnelson, M.D. “We will be able to offer the most advanced minimally invasive procedures to treat liver